Literature DB >> 17344190

Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat.

Noel M Caplice1, Shaohua Wang, Michal Tracz, Anthony J Croatt, Joseph P Grande, Zvonimir S Katusic, Karl A Nath.   

Abstract

Venous injury and attendant venous stenosis are major contributors to the failure of hemodialysis vascular accesses. This report describes the presence of neoangiogenesis in the intima and adventitia of the venous limb of an arteriovenous (AV) fistula in the rat, the latter induced by creating an aortocaval fistula. Immunohistochemistry of the venous limb demonstrated the presence of c-Kit-positive cells lining new microvessels with lumen formation and that these c-Kit-positive cells exhibited either a smooth muscle phenotype as reflected by concomitant expression of calponin, or an endothelial phenotype as reflected by expression of endothelial nitric oxide synthase (eNOS). Western analysis confirmed upregulation of eNOS in the venous limb of the AV fistula. Measurement of systemic concentrations of angiogenic cytokines, namely, monocyte chemotactic protein-1, stromal cell-derived factor-1 (SDF-1), cytokine-induced neutrophil chemoattractant, and VEGF, failed to reveal an increase in these cytokines either at 3 or 10 wk after creation of the AV fistula. The angiogenic cytokines VEGF and SDF-1 were not upregulated in the venous limb of the AV fistula either at 2 or 16 wk. We conclude that in this model of an AV fistula in the rat, neoangiogenesis occurs and is constituted, at least in part, by bone marrow-derived cells, the latter differentiating to exhibit either an endothelial or smooth muscle phenotype. In view of these findings, we suggest that this model may offer an experimental approach by which to explore the evolution and significance of neoangiogenesis in the formation and pathobiology of vascular plaques, and the mechanisms that promote dysfunction of hemodialysis AV fistulas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344190      PMCID: PMC2918263          DOI: 10.1152/ajprenal.00067.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  42 in total

1.  Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access.

Authors:  M F Weiss; V Scivittaro; J M Anderson
Journal:  Am J Kidney Dis       Date:  2001-05       Impact factor: 8.860

Review 2.  Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia.

Authors:  Amit K Mitra; Deepak M Gangahar; Devendra K Agrawal
Journal:  Immunol Cell Biol       Date:  2006-04       Impact factor: 5.126

3.  Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas.

Authors:  Sylvia Stracke; Klaus Konner; Isabella Köstlin; Reinhard Friedl; Peter M Jehle; Vinzenz Hombach; Frieder Keller; Johannes Waltenberger
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

Review 4.  Why don't fistulas mature?

Authors:  B S Dixon
Journal:  Kidney Int       Date:  2006-08-02       Impact factor: 10.612

5.  Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis.

Authors:  Burnett S Kelly; Sue C Heffelfinger; James F Whiting; Mary Ann Miller; Anita Reaves; Janice Armstrong; Ashwath Narayana; Prabir Roy-Chaudhury
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

Review 6.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

Review 7.  Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions.

Authors:  Michael Allon; Michelle L Robbin
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

8.  Heme oxygenase-1 is expressed in carotid atherosclerotic plaques infected by Helicobacter pylori and is more prevalent in asymptomatic subjects.

Authors:  Sebastian F Ameriso; Agustina Ruiz Villamil; Christine Zedda; Juan C Parodi; Sergio Garrido; María Inés Sarchi; Marcelo Schultz; Jorge Boczkowski; Gustavo E Sevlever
Journal:  Stroke       Date:  2005-08-11       Impact factor: 7.914

9.  Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients.

Authors:  Gunnar H Heine; Christof Ulrich; Urban Sester; Martina Sester; Hans Köhler; Matthias Girndt
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

10.  Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells.

Authors:  Soichiro Fujiyama; Katsuya Amano; Kazutaka Uehira; Masayuki Yoshida; Yasunobu Nishiwaki; Yoshihisa Nozawa; Denan Jin; Shinji Takai; Mizuo Miyazaki; Kensuke Egashira; Takayuki Imada; Toshiji Iwasaka; Hiroaki Matsubara
Journal:  Circ Res       Date:  2003-10-02       Impact factor: 17.367

View more
  22 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

2.  Objectives and design of the hemodialysis fistula maturation study.

Authors:  Laura M Dember; Peter B Imrey; Gerald J Beck; Alfred K Cheung; Jonathan Himmelfarb; Thomas S Huber; John W Kusek; Prabir Roy-Chaudhury; Miguel A Vazquez; Charles E Alpers; Michelle L Robbin; Joseph A Vita; Tom Greene; Jennifer J Gassman; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2013-08-28       Impact factor: 8.860

3.  Technical aspects of the mouse aortocaval fistula.

Authors:  Kota Yamamoto; Xin Li; Chang Shu; Tetsuro Miyata; Alan Dardik
Journal:  J Vis Exp       Date:  2013-07-11       Impact factor: 1.355

4.  The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.

Authors:  Wenguang Feng; Phillip Chumley; Michael Allon; James George; David W Scott; Rakesh P Patel; Silvio Litovsky; Edgar A Jaimes
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

5.  Establishment of a rat autogenous arteriovenous fistula model following 5/6 nephrectomy.

Authors:  Chenfei Zheng; Ying Zhou; Chaoxing Huang; Zhouchang Zhang; Y I Liu; Yulan Xu
Journal:  Exp Ther Med       Date:  2015-04-24       Impact factor: 2.447

Review 6.  New Insights into Dialysis Vascular Access: Molecular Targets in Arteriovenous Fistula and Arteriovenous Graft Failure and Their Potential to Improve Vascular Access Outcomes.

Authors:  Timmy Lee; Sanjay Misra
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

7.  c-Kit suppresses atherosclerosis in hyperlipidemic mice.

Authors:  Lei Song; Zachary M Zigmond; Laisel Martinez; Roberta M Lassance-Soares; Alejandro E Macias; Omaida C Velazquez; Zhao-Jun Liu; Alghidak Salama; Keith A Webster; Roberto I Vazquez-Padron
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-23       Impact factor: 4.733

Review 8.  Vein graft adaptation and fistula maturation in the arterial environment.

Authors:  Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik
Journal:  J Surg Res       Date:  2014-01-30       Impact factor: 2.192

9.  The mouse aortocaval fistula recapitulates human arteriovenous fistula maturation.

Authors:  Kota Yamamoto; Clinton D Protack; Masayuki Tsuneki; Michael R Hall; Daniel J Wong; Daniel Y Lu; Roland Assi; Willis T Williams; Nirvana Sadaghianloo; Hualong Bai; Tetsuro Miyata; Joseph A Madri; Alan Dardik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-04       Impact factor: 4.733

Review 10.  Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis.

Authors:  Timmy Lee; Prabir Roy-Chaudhury
Journal:  Adv Chronic Kidney Dis       Date:  2009-09       Impact factor: 3.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.